KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2025)

Ionis Pharmaceuticals (IONS) has 7 years of Exchange Rate Effect data on record, last reported at -$43000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 91.15% year-over-year to -$43000.0; the TTM value through Dec 2025 reached $702000.0, up 357.14%, while the annual FY2025 figure was $702000.0, 357.14% up from the prior year.
  • Exchange Rate Effect reached -$43000.0 in Q4 2025 per IONS's latest filing, up from -$82000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $595000.0 in Q2 2025 and bottomed at -$486000.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $12600.0, with a median of -$33000.0 recorded in 2024.
  • Peak YoY movement for Exchange Rate Effect: plummeted 1800.0% in 2022, then skyrocketed 2686.96% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$68000.0 in 2021, then skyrocketed by 902.94% to $546000.0 in 2022, then crashed by 39.56% to $330000.0 in 2023, then crashed by 247.27% to -$486000.0 in 2024, then soared by 91.15% to -$43000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$43000.0 in Q4 2025, -$82000.0 in Q3 2025, and $595000.0 in Q2 2025.